UnitedHealth Group recorded revenues north of $80 billion in Q2, boosted by double-digit growth from Optum and UnitedHealthcare, according to the company’s earnings released Friday morning.
Optum recorded revenues of $45.1 billion during the quarter, up $6.8 billion year-over-year, while UnitedHealthcare generated $62.1 billion, up $6.6 billion over the same period. OptumRx reported revenue growth of 10%, noting that pharmacy care service offerings expanded while adjusted scripts increased from 342 million to 357 million.
The strong performance during the quarter prompted UnitedHealth to boost its full-year earnings outlook to $20.45 to $20.95 per share.
“Customers are responding as we build on our five growth pillars, enabling us to move into the second half of 2022 with strong momentum serving ever more people more deeply,” CEO Andrew Witty said in a statement.
